Global CAR T-Cell Immunotherapy Market Growth (Status and Outlook) 2025-2031
According to this study, the global CAR T-Cell Immunotherapy market size will reach US$ million by 2031.
CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
United States market for CAR T-Cell Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for CAR T-Cell Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for CAR T-Cell Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key CAR T-Cell Immunotherapy players cover AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “CAR T-Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world CAR T-Cell Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected CAR T-Cell Immunotherapy sales for 2025 through 2031. With CAR T-Cell Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-Cell Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global CAR T-Cell Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR T-Cell Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR T-Cell Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-Cell Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-Cell Immunotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
United States market for CAR T-Cell Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for CAR T-Cell Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for CAR T-Cell Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key CAR T-Cell Immunotherapy players cover AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “CAR T-Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world CAR T-Cell Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected CAR T-Cell Immunotherapy sales for 2025 through 2031. With CAR T-Cell Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-Cell Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global CAR T-Cell Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR T-Cell Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR T-Cell Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-Cell Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-Cell Immunotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Monotherapy
- Combination Therapy
- Hematologic Malignancies
- Solid Malignancies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Celgene
- Kite Pharma
- Oxford BioMedica
- Novartis
- Gilead
- Pfizer
- Cellectis
- Bellicum
- Mustang Bio
- CARsgen Therapeutics
- Xyphos
- Minerva Biotechnologies
- Adaptimmune
- Ziopharm Oncology
- Aurora Biopharma
- Creative Biolabs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell Immunotherapy Market Size (2020-2031)
2.1.2 CAR T-Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CAR T-Cell Immunotherapy by Country/Region (2020, 2024 & 2031)
2.2 CAR T-Cell Immunotherapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 CAR T-Cell Immunotherapy Market Size by Type
2.3.1 CAR T-Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
2.4 CAR T-Cell Immunotherapy Segment by Application
2.4.1 Hematologic Malignancies
2.4.2 Solid Malignancies
2.5 CAR T-Cell Immunotherapy Market Size by Application
2.5.1 CAR T-Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
3 CAR T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 CAR T-Cell Immunotherapy Market Size Market Share by Player
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Player (2020-2025)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL IMMUNOTHERAPY BY REGION
4.1 CAR T-Cell Immunotherapy Market Size by Region (2020-2025)
4.2 Global CAR T-Cell Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
4.4 APAC CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
4.5 Europe CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CAR T-Cell Immunotherapy Market Size by Country (2020-2025)
5.2 Americas CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
5.3 Americas CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Immunotherapy Market Size by Region (2020-2025)
6.2 APAC CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
6.3 APAC CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell Immunotherapy Market Size by Country (2020-2025)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell Immunotherapy by Region (2020-2025)
8.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET FORECAST
10.1 Global CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.1.1 Global CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.1.2 Americas CAR T-Cell Immunotherapy Forecast
10.1.3 APAC CAR T-Cell Immunotherapy Forecast
10.1.4 Europe CAR T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast
10.2 Americas CAR T-Cell Immunotherapy Forecast by Country (2026-2031)
10.2.1 United States Market CAR T-Cell Immunotherapy Forecast
10.2.2 Canada Market CAR T-Cell Immunotherapy Forecast
10.2.3 Mexico Market CAR T-Cell Immunotherapy Forecast
10.2.4 Brazil Market CAR T-Cell Immunotherapy Forecast
10.3 APAC CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.3.1 China CAR T-Cell Immunotherapy Market Forecast
10.3.2 Japan Market CAR T-Cell Immunotherapy Forecast
10.3.3 Korea Market CAR T-Cell Immunotherapy Forecast
10.3.4 Southeast Asia Market CAR T-Cell Immunotherapy Forecast
10.3.5 India Market CAR T-Cell Immunotherapy Forecast
10.3.6 Australia Market CAR T-Cell Immunotherapy Forecast
10.4 Europe CAR T-Cell Immunotherapy Forecast by Country (2026-2031)
10.4.1 Germany Market CAR T-Cell Immunotherapy Forecast
10.4.2 France Market CAR T-Cell Immunotherapy Forecast
10.4.3 UK Market CAR T-Cell Immunotherapy Forecast
10.4.4 Italy Market CAR T-Cell Immunotherapy Forecast
10.4.5 Russia Market CAR T-Cell Immunotherapy Forecast
10.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.5.1 Egypt Market CAR T-Cell Immunotherapy Forecast
10.5.2 South Africa Market CAR T-Cell Immunotherapy Forecast
10.5.3 Israel Market CAR T-Cell Immunotherapy Forecast
10.5.4 Turkey Market CAR T-Cell Immunotherapy Forecast
10.6 Global CAR T-Cell Immunotherapy Forecast by Type (2026-2031)
10.7 Global CAR T-Cell Immunotherapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CAR T-Cell Immunotherapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie CAR T-Cell Immunotherapy Product Offered
11.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene CAR T-Cell Immunotherapy Product Offered
11.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Kite Pharma
11.3.1 Kite Pharma Company Information
11.3.2 Kite Pharma CAR T-Cell Immunotherapy Product Offered
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Kite Pharma Main Business Overview
11.3.5 Kite Pharma Latest Developments
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Information
11.4.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Oxford BioMedica Main Business Overview
11.4.5 Oxford BioMedica Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis CAR T-Cell Immunotherapy Product Offered
11.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Gilead
11.6.1 Gilead Company Information
11.6.2 Gilead CAR T-Cell Immunotherapy Product Offered
11.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Gilead Main Business Overview
11.6.5 Gilead Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer CAR T-Cell Immunotherapy Product Offered
11.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Cellectis
11.8.1 Cellectis Company Information
11.8.2 Cellectis CAR T-Cell Immunotherapy Product Offered
11.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Cellectis Main Business Overview
11.8.5 Cellectis Latest Developments
11.9 Bellicum
11.9.1 Bellicum Company Information
11.9.2 Bellicum CAR T-Cell Immunotherapy Product Offered
11.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bellicum Main Business Overview
11.9.5 Bellicum Latest Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio CAR T-Cell Immunotherapy Product Offered
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mustang Bio Main Business Overview
11.10.5 Mustang Bio Latest Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Information
11.11.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 CARsgen Therapeutics Main Business Overview
11.11.5 CARsgen Therapeutics Latest Developments
11.12 Xyphos
11.12.1 Xyphos Company Information
11.12.2 Xyphos CAR T-Cell Immunotherapy Product Offered
11.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Xyphos Main Business Overview
11.12.5 Xyphos Latest Developments
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Information
11.13.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Minerva Biotechnologies Main Business Overview
11.13.5 Minerva Biotechnologies Latest Developments
11.14 Adaptimmune
11.14.1 Adaptimmune Company Information
11.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Offered
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Adaptimmune Main Business Overview
11.14.5 Adaptimmune Latest Developments
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Information
11.15.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Ziopharm Oncology Main Business Overview
11.15.5 Ziopharm Oncology Latest Developments
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Information
11.16.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Aurora Biopharma Main Business Overview
11.16.5 Aurora Biopharma Latest Developments
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Information
11.17.2 Creative Biolabs CAR T-Cell Immunotherapy Product Offered
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Creative Biolabs Main Business Overview
11.17.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell Immunotherapy Market Size (2020-2031)
2.1.2 CAR T-Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CAR T-Cell Immunotherapy by Country/Region (2020, 2024 & 2031)
2.2 CAR T-Cell Immunotherapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 CAR T-Cell Immunotherapy Market Size by Type
2.3.1 CAR T-Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
2.4 CAR T-Cell Immunotherapy Segment by Application
2.4.1 Hematologic Malignancies
2.4.2 Solid Malignancies
2.5 CAR T-Cell Immunotherapy Market Size by Application
2.5.1 CAR T-Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
3 CAR T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 CAR T-Cell Immunotherapy Market Size Market Share by Player
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Player (2020-2025)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL IMMUNOTHERAPY BY REGION
4.1 CAR T-Cell Immunotherapy Market Size by Region (2020-2025)
4.2 Global CAR T-Cell Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
4.4 APAC CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
4.5 Europe CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CAR T-Cell Immunotherapy Market Size by Country (2020-2025)
5.2 Americas CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
5.3 Americas CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Immunotherapy Market Size by Region (2020-2025)
6.2 APAC CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
6.3 APAC CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell Immunotherapy Market Size by Country (2020-2025)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell Immunotherapy by Region (2020-2025)
8.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET FORECAST
10.1 Global CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.1.1 Global CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.1.2 Americas CAR T-Cell Immunotherapy Forecast
10.1.3 APAC CAR T-Cell Immunotherapy Forecast
10.1.4 Europe CAR T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast
10.2 Americas CAR T-Cell Immunotherapy Forecast by Country (2026-2031)
10.2.1 United States Market CAR T-Cell Immunotherapy Forecast
10.2.2 Canada Market CAR T-Cell Immunotherapy Forecast
10.2.3 Mexico Market CAR T-Cell Immunotherapy Forecast
10.2.4 Brazil Market CAR T-Cell Immunotherapy Forecast
10.3 APAC CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.3.1 China CAR T-Cell Immunotherapy Market Forecast
10.3.2 Japan Market CAR T-Cell Immunotherapy Forecast
10.3.3 Korea Market CAR T-Cell Immunotherapy Forecast
10.3.4 Southeast Asia Market CAR T-Cell Immunotherapy Forecast
10.3.5 India Market CAR T-Cell Immunotherapy Forecast
10.3.6 Australia Market CAR T-Cell Immunotherapy Forecast
10.4 Europe CAR T-Cell Immunotherapy Forecast by Country (2026-2031)
10.4.1 Germany Market CAR T-Cell Immunotherapy Forecast
10.4.2 France Market CAR T-Cell Immunotherapy Forecast
10.4.3 UK Market CAR T-Cell Immunotherapy Forecast
10.4.4 Italy Market CAR T-Cell Immunotherapy Forecast
10.4.5 Russia Market CAR T-Cell Immunotherapy Forecast
10.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast by Region (2026-2031)
10.5.1 Egypt Market CAR T-Cell Immunotherapy Forecast
10.5.2 South Africa Market CAR T-Cell Immunotherapy Forecast
10.5.3 Israel Market CAR T-Cell Immunotherapy Forecast
10.5.4 Turkey Market CAR T-Cell Immunotherapy Forecast
10.6 Global CAR T-Cell Immunotherapy Forecast by Type (2026-2031)
10.7 Global CAR T-Cell Immunotherapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CAR T-Cell Immunotherapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie CAR T-Cell Immunotherapy Product Offered
11.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene CAR T-Cell Immunotherapy Product Offered
11.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Kite Pharma
11.3.1 Kite Pharma Company Information
11.3.2 Kite Pharma CAR T-Cell Immunotherapy Product Offered
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Kite Pharma Main Business Overview
11.3.5 Kite Pharma Latest Developments
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Information
11.4.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Oxford BioMedica Main Business Overview
11.4.5 Oxford BioMedica Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis CAR T-Cell Immunotherapy Product Offered
11.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Gilead
11.6.1 Gilead Company Information
11.6.2 Gilead CAR T-Cell Immunotherapy Product Offered
11.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Gilead Main Business Overview
11.6.5 Gilead Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer CAR T-Cell Immunotherapy Product Offered
11.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Cellectis
11.8.1 Cellectis Company Information
11.8.2 Cellectis CAR T-Cell Immunotherapy Product Offered
11.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Cellectis Main Business Overview
11.8.5 Cellectis Latest Developments
11.9 Bellicum
11.9.1 Bellicum Company Information
11.9.2 Bellicum CAR T-Cell Immunotherapy Product Offered
11.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bellicum Main Business Overview
11.9.5 Bellicum Latest Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio CAR T-Cell Immunotherapy Product Offered
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mustang Bio Main Business Overview
11.10.5 Mustang Bio Latest Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Information
11.11.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 CARsgen Therapeutics Main Business Overview
11.11.5 CARsgen Therapeutics Latest Developments
11.12 Xyphos
11.12.1 Xyphos Company Information
11.12.2 Xyphos CAR T-Cell Immunotherapy Product Offered
11.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Xyphos Main Business Overview
11.12.5 Xyphos Latest Developments
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Information
11.13.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Minerva Biotechnologies Main Business Overview
11.13.5 Minerva Biotechnologies Latest Developments
11.14 Adaptimmune
11.14.1 Adaptimmune Company Information
11.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Offered
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Adaptimmune Main Business Overview
11.14.5 Adaptimmune Latest Developments
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Information
11.15.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Ziopharm Oncology Main Business Overview
11.15.5 Ziopharm Oncology Latest Developments
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Information
11.16.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Aurora Biopharma Main Business Overview
11.16.5 Aurora Biopharma Latest Developments
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Information
11.17.2 Creative Biolabs CAR T-Cell Immunotherapy Product Offered
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Creative Biolabs Main Business Overview
11.17.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR T-Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CAR T-Cell Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monotherapy
Table 4. Major Players of Combination Therapy
Table 5. CAR T-Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Table 8. CAR T-Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 11. Global CAR T-Cell Immunotherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global CAR T-Cell Immunotherapy Revenue Market Share by Player (2020-2025)
Table 13. CAR T-Cell Immunotherapy Key Players Head office and Products Offered
Table 14. CAR T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CAR T-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 19. Global CAR T-Cell Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global CAR T-Cell Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas CAR T-Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas CAR T-Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Table 25. Americas CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC CAR T-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe CAR T-Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CAR T-Cell Immunotherapy
Table 39. Key Market Challenges & Risks of CAR T-Cell Immunotherapy
Table 40. Key Industry Trends of CAR T-Cell Immunotherapy
Table 41. Global CAR T-Cell Immunotherapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global CAR T-Cell Immunotherapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global CAR T-Cell Immunotherapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AbbVie Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 46. AbbVie CAR T-Cell Immunotherapy Product Offered
Table 47. AbbVie CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AbbVie Main Business
Table 49. AbbVie Latest Developments
Table 50. Celgene Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 51. Celgene CAR T-Cell Immunotherapy Product Offered
Table 52. Celgene CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Celgene Main Business
Table 54. Celgene Latest Developments
Table 55. Kite Pharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 56. Kite Pharma CAR T-Cell Immunotherapy Product Offered
Table 57. Kite Pharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Kite Pharma Main Business
Table 59. Kite Pharma Latest Developments
Table 60. Oxford BioMedica Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 61. Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
Table 62. Oxford BioMedica CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Oxford BioMedica Main Business
Table 64. Oxford BioMedica Latest Developments
Table 65. Novartis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 66. Novartis CAR T-Cell Immunotherapy Product Offered
Table 67. Novartis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Gilead Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 71. Gilead CAR T-Cell Immunotherapy Product Offered
Table 72. Gilead CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Gilead Main Business
Table 74. Gilead Latest Developments
Table 75. Pfizer Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 76. Pfizer CAR T-Cell Immunotherapy Product Offered
Table 77. Pfizer CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Cellectis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 81. Cellectis CAR T-Cell Immunotherapy Product Offered
Table 82. Cellectis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Cellectis Main Business
Table 84. Cellectis Latest Developments
Table 85. Bellicum Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 86. Bellicum CAR T-Cell Immunotherapy Product Offered
Table 87. Bellicum CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Bellicum Main Business
Table 89. Bellicum Latest Developments
Table 90. Mustang Bio Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 91. Mustang Bio CAR T-Cell Immunotherapy Product Offered
Table 92. Mustang Bio CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Mustang Bio Main Business
Table 94. Mustang Bio Latest Developments
Table 95. CARsgen Therapeutics Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 96. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
Table 97. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. CARsgen Therapeutics Main Business
Table 99. CARsgen Therapeutics Latest Developments
Table 100. Xyphos Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 101. Xyphos CAR T-Cell Immunotherapy Product Offered
Table 102. Xyphos CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Xyphos Main Business
Table 104. Xyphos Latest Developments
Table 105. Minerva Biotechnologies Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 106. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
Table 107. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Minerva Biotechnologies Main Business
Table 109. Minerva Biotechnologies Latest Developments
Table 110. Adaptimmune Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 111. Adaptimmune CAR T-Cell Immunotherapy Product Offered
Table 112. Adaptimmune CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Adaptimmune Main Business
Table 114. Adaptimmune Latest Developments
Table 115. Ziopharm Oncology Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 116. Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
Table 117. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Ziopharm Oncology Main Business
Table 119. Ziopharm Oncology Latest Developments
Table 120. Aurora Biopharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 121. Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
Table 122. Aurora Biopharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Aurora Biopharma Main Business
Table 124. Aurora Biopharma Latest Developments
Table 125. Creative Biolabs Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 126. Creative Biolabs CAR T-Cell Immunotherapy Product Offered
Table 127. Creative Biolabs CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Creative Biolabs Main Business
Table 129. Creative Biolabs Latest Developments
Table 1. CAR T-Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CAR T-Cell Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monotherapy
Table 4. Major Players of Combination Therapy
Table 5. CAR T-Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Table 8. CAR T-Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 11. Global CAR T-Cell Immunotherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global CAR T-Cell Immunotherapy Revenue Market Share by Player (2020-2025)
Table 13. CAR T-Cell Immunotherapy Key Players Head office and Products Offered
Table 14. CAR T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CAR T-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 19. Global CAR T-Cell Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global CAR T-Cell Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas CAR T-Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas CAR T-Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Table 25. Americas CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC CAR T-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe CAR T-Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CAR T-Cell Immunotherapy
Table 39. Key Market Challenges & Risks of CAR T-Cell Immunotherapy
Table 40. Key Industry Trends of CAR T-Cell Immunotherapy
Table 41. Global CAR T-Cell Immunotherapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global CAR T-Cell Immunotherapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global CAR T-Cell Immunotherapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AbbVie Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 46. AbbVie CAR T-Cell Immunotherapy Product Offered
Table 47. AbbVie CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AbbVie Main Business
Table 49. AbbVie Latest Developments
Table 50. Celgene Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 51. Celgene CAR T-Cell Immunotherapy Product Offered
Table 52. Celgene CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Celgene Main Business
Table 54. Celgene Latest Developments
Table 55. Kite Pharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 56. Kite Pharma CAR T-Cell Immunotherapy Product Offered
Table 57. Kite Pharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Kite Pharma Main Business
Table 59. Kite Pharma Latest Developments
Table 60. Oxford BioMedica Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 61. Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
Table 62. Oxford BioMedica CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Oxford BioMedica Main Business
Table 64. Oxford BioMedica Latest Developments
Table 65. Novartis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 66. Novartis CAR T-Cell Immunotherapy Product Offered
Table 67. Novartis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Gilead Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 71. Gilead CAR T-Cell Immunotherapy Product Offered
Table 72. Gilead CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Gilead Main Business
Table 74. Gilead Latest Developments
Table 75. Pfizer Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 76. Pfizer CAR T-Cell Immunotherapy Product Offered
Table 77. Pfizer CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Cellectis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 81. Cellectis CAR T-Cell Immunotherapy Product Offered
Table 82. Cellectis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Cellectis Main Business
Table 84. Cellectis Latest Developments
Table 85. Bellicum Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 86. Bellicum CAR T-Cell Immunotherapy Product Offered
Table 87. Bellicum CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Bellicum Main Business
Table 89. Bellicum Latest Developments
Table 90. Mustang Bio Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 91. Mustang Bio CAR T-Cell Immunotherapy Product Offered
Table 92. Mustang Bio CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Mustang Bio Main Business
Table 94. Mustang Bio Latest Developments
Table 95. CARsgen Therapeutics Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 96. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
Table 97. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. CARsgen Therapeutics Main Business
Table 99. CARsgen Therapeutics Latest Developments
Table 100. Xyphos Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 101. Xyphos CAR T-Cell Immunotherapy Product Offered
Table 102. Xyphos CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Xyphos Main Business
Table 104. Xyphos Latest Developments
Table 105. Minerva Biotechnologies Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 106. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
Table 107. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Minerva Biotechnologies Main Business
Table 109. Minerva Biotechnologies Latest Developments
Table 110. Adaptimmune Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 111. Adaptimmune CAR T-Cell Immunotherapy Product Offered
Table 112. Adaptimmune CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Adaptimmune Main Business
Table 114. Adaptimmune Latest Developments
Table 115. Ziopharm Oncology Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 116. Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
Table 117. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Ziopharm Oncology Main Business
Table 119. Ziopharm Oncology Latest Developments
Table 120. Aurora Biopharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 121. Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
Table 122. Aurora Biopharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Aurora Biopharma Main Business
Table 124. Aurora Biopharma Latest Developments
Table 125. Creative Biolabs Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 126. Creative Biolabs CAR T-Cell Immunotherapy Product Offered
Table 127. Creative Biolabs CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Creative Biolabs Main Business
Table 129. Creative Biolabs Latest Developments
LIST OF FIGURES
Figure 1. CAR T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-Cell Immunotherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CAR T-Cell Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CAR T-Cell Immunotherapy Sales Market Share by Country/Region (2024)
Figure 8. CAR T-Cell Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CAR T-Cell Immunotherapy Market Size Market Share by Type in 2024
Figure 10. CAR T-Cell Immunotherapy in Hematologic Malignancies
Figure 11. Global CAR T-Cell Immunotherapy Market: Hematologic Malignancies (2020-2025) & ($ millions)
Figure 12. CAR T-Cell Immunotherapy in Solid Malignancies
Figure 13. Global CAR T-Cell Immunotherapy Market: Solid Malignancies (2020-2025) & ($ millions)
Figure 14. Global CAR T-Cell Immunotherapy Market Size Market Share by Application in 2024
Figure 15. Global CAR T-Cell Immunotherapy Revenue Market Share by Player in 2024
Figure 16. Global CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 18. APAC CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 19. Europe CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 21. Americas CAR T-Cell Immunotherapy Value Market Share by Country in 2024
Figure 22. United States CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region in 2024
Figure 27. APAC CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 29. China CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country in 2024
Figure 36. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 52. APAC CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 53. Europe CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 55. United States CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 56. Canada CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 59. China CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 60. Japan CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 61. Korea CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 63. India CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 64. Australia CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 65. Germany CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 66. France CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 67. UK CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 68. Italy CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 69. Russia CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 72. Israel CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 74. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 1. CAR T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-Cell Immunotherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CAR T-Cell Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CAR T-Cell Immunotherapy Sales Market Share by Country/Region (2024)
Figure 8. CAR T-Cell Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CAR T-Cell Immunotherapy Market Size Market Share by Type in 2024
Figure 10. CAR T-Cell Immunotherapy in Hematologic Malignancies
Figure 11. Global CAR T-Cell Immunotherapy Market: Hematologic Malignancies (2020-2025) & ($ millions)
Figure 12. CAR T-Cell Immunotherapy in Solid Malignancies
Figure 13. Global CAR T-Cell Immunotherapy Market: Solid Malignancies (2020-2025) & ($ millions)
Figure 14. Global CAR T-Cell Immunotherapy Market Size Market Share by Application in 2024
Figure 15. Global CAR T-Cell Immunotherapy Revenue Market Share by Player in 2024
Figure 16. Global CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 18. APAC CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 19. Europe CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 21. Americas CAR T-Cell Immunotherapy Value Market Share by Country in 2024
Figure 22. United States CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region in 2024
Figure 27. APAC CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 29. China CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country in 2024
Figure 36. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries CAR T-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 52. APAC CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 53. Europe CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 55. United States CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 56. Canada CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 59. China CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 60. Japan CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 61. Korea CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 63. India CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 64. Australia CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 65. Germany CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 66. France CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 67. UK CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 68. Italy CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 69. Russia CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 72. Israel CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 74. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries CAR T-Cell Immunotherapy Market Size 2026-2031 ($ millions)
More Publications
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2017
US$ 2,950.00
November 2017
385 pages
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Pipeline and Market Analysis, 2018
US$ 2,950.00
October 2018
289 pages
Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2024
102 pages
Global Circulating Tumor Cells Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
130 pages
Global Competent Cells Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
159 pages
